Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles.
Source check: Source checked. Not independent scientific confirmation.
Finding: XGBoost with feature selection yields 118 validated cell-line drug-response models for 62 drugs across five cancer types using four omics profiles; validation is on the source pharmacogenomic datasets, not clinical patient response. External replication and prospective utility were not established in the reviewed material.
Technology: XGBoost polygenic models with feature selection trained on multi-omics pharmacogenomic profiles
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- XGBoost polygenic models with feature selection trained on multi-omics pharmacogenomic profiles
- Test and result
- XGBoost with feature selection yields 118 validated cell-line drug-response models for 62 drugs across five cancer types using four omics profiles; validation is on the source pharmacogenomic datasets, not clinical patient response.
- Limitation / still unknown
- External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/biomolecules/biomolecules-10-00963/article_deploy/biomolecules-10-00963.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.